The packaging capacity of adeno-associated virus (AAV) and the potential for wild-type-plus AAV gene therapy vectors

scientific article published in April 1997

The packaging capacity of adeno-associated virus (AAV) and the potential for wild-type-plus AAV gene therapy vectors is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/S0014-5793(97)00311-6
P698PubMed publication ID9141485

P2093author name stringHan L
Hermonat PL
Quirk JG
Bishop BM
P2860cites workSite-specific integration by adeno-associated virusQ24558738
Adeno-associated virus (AAV) Rep proteins mediate complex formation between AAV DNA and its integration site in human DNAQ24562760
Detection of specific sequences among DNA fragments separated by gel electrophoresisQ25939003
Selective extraction of polyoma DNA from infected mouse cell culturesQ29547500
Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cellsQ33914608
Isolation of a lentivirus from a macaque with lymphoma: comparison with HTLV-III/LAV and other lentiviruses.Q33927613
DNA synthesis and topoisomerase inhibitors increase transduction by adeno-associated virus vectorsQ34251868
Site-specific integration by adeno-associated virus is directed by a cellular DNA sequenceQ35829692
Targeted integration of adeno-associated virus (AAV) into human chromosome 19Q35936149
Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cellsQ36288360
Adeno-associated virus vector for high-frequency integration, expression, and rescue of genes in mammalian cellsQ36425596
Adeno-associated virus general transduction vectors: analysis of proviral structuresQ36868692
Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutantsQ36893013
Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cellsQ37573696
Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell typesQ40660263
High-efficiency transfer of the T cell co-stimulatory molecule B7-2 to lymphoid cells using high-titer recombinant adeno-associated virus vectorsQ41263327
High prevalence of adeno-associated virus (AAV) type 2 rep DNA in cervical materials: AAV may be sexually transmittedQ45767111
The regulatory rep protein of adeno-associated virus binds to sequences within the c-H-ras promoterQ45782486
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectgene therapyQ213901
vector-borne diseaseQ2083837
P304page(s)78-84
P577publication date1997-04-01
P1433published inFEBS LettersQ1388051
P1476titleThe packaging capacity of adeno-associated virus (AAV) and the potential for wild-type-plus AAV gene therapy vectors
P478volume407

Reverse relations

cites work (P2860)
Q34306694AAV2/8-hSMAD3 gene delivery attenuates aortic atherogenesis, enhances Th2 response without fibrosis, in LDLR-KO mice on high cholesterol diet
Q36165834Adeno-associated virus vectors: potential applications for cancer gene therapy
Q90259836Biomaterial-guided delivery of gene vectors for targeted articular cartilage repair
Q33576852Characterization of genome integrity for oversized recombinant AAV vector
Q33836499DNA as therapeutics; an update
Q41093443Delivering Transgenic DNA Exceeding the Carrying Capacity of AAV Vectors
Q40138075Development of In Vivo Imaging Tools for Investigating Astrocyte Activation in Epileptogenesis
Q37591108Effective delivery of large genes to the retina by dual AAV vectors
Q97527308Effects of Thermally Induced Configuration Changes on rAAV Genome's Enzymatic Accessibility
Q42235082Efficient gene delivery to the cone-enriched pig retina by dual AAV vectors
Q43983069Efficient generation of cytotoxic T lymphocytes against cervical cancer cells by adeno-associated virus/human papillomavirus type 16 E7 antigen gene transduction into dendritic cells
Q45571369Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6.
Q36601946Expressing Transgenes That Exceed the Packaging Capacity of Adeno-Associated Virus Capsids
Q39576163Extending the transposable payload limit of Sleeping Beauty (SB) using the Herpes Simplex Virus (HSV)/SB amplicon-vector platform
Q42270238Full-length dysferlin expression driven by engineered human dystrophic blood derived CD133+ stem cells
Q34987213Gene delivery to the eye using adeno-associated viral vectors
Q28086805Gene therapy for cancer: regulatory considerations for approval
Q35943998Gene therapy for optic nerve disease
Q55000684Guiding Lights in Genome Editing for Inherited Retinal Disorders: Implications for Gene and Cell Therapy.
Q33729610Harnessing the Potential of Human Pluripotent Stem Cells and Gene Editing for the Treatment of Retinal Degeneration
Q54981136High-throughput screening identifies kinase inhibitors that increase dual AAV vectors transduction in vitro and in mouse retina.
Q27300915Homologous recombination mediates functional recovery of dysferlin deficiency following AAV5 gene transfer
Q39639471Little vector, big gene transduction: fragmented genome reassembly of adeno-associated virus
Q34586568Novel gene therapy viral vector using non-oncogenic lymphotropic herpesvirus
Q37684186Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons
Q33315726Optimized cDNA libraries for virus-induced gene silencing (VIGS) using tobacco rattle virus
Q24533013Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps
Q34343763Proteasome inhibitors enhance gene delivery by AAV virus vectors expressing large genomes in hemophilia mouse and dog models: a strategy for broad clinical application
Q45735544Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes.
Q45734168Rapid induction of cytotoxic T-cell response against cervical cancer cells by human papillomavirus type 16 E6 antigen gene delivery into human dendritic cells by an adeno-associated virus vector
Q40933734Recombinant AAV-2 harboring gfp-antisense/ribozyme fusion sequences monitor transduction, gene expression, and show anti-HIV-1 efficacy
Q34804660Self-complementary AAV vectors; advances and applications
Q36545533Serotype-dependent packaging of large genes in adeno-associated viral vectors results in effective gene delivery in mice.
Q26766232The therapeutic potential of genome editing for β-thalassemia
Q36729692The use of recombinant adeno-associated virus for skeletal gene therapy
Q47559127Triple Vectors Expand AAV Transfer Capacity in the Retina

Search more.